Back to Search
Start Over
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
- Source :
-
Leukemia [Leukemia] 2018 Apr; Vol. 32 (4), pp. 1054. Date of Electronic Publication: 2018 Jan 30. - Publication Year :
- 2018
-
Abstract
- This corrects the article DOI: 10.1038/leu.2017.9.
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 29381150
- Full Text :
- https://doi.org/10.1038/leu.2017.348